Maxwell DeNies
InvestorAnalyst at RA Capital
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Maxwell DeNies is an Analyst on the investment team at RA Capital Management, where he conducts due diligence on biotechnology companies and advises portfolio companies on program and pipeline strategy. He holds a BS in Biology from the State University of New York at Fredonia and a PhD in Cellular and Molecular Biology from the University of Michigan. He joined RA Capital in 2020.
Invests in
Biotech
Experience
- RA Capital Management, L.P.Senior Associatecurrent2022 — presentBoston, Massachusetts, United States
- RA Capital Management, L.P.Associate2020 — 2022Boston, Massachusetts, United States
- University of MichiganGraduate Student2014 — 2020Ann Arbor Michigan
- University of Michigan Ross School of BusinessWolverine Venture Fund Student Advisor2016 — 2020Ann Arbor Michigan
- SUNY FredoniaCTS Tutor2012 — 2014Buffalo-Niagara Falls Area
- SUNY FredoniaUndergraduate Researcher2012 — 2014Buffalo-Niagara Falls Area
- UCSFVisiting Student Researcher2013San Francisco Bay Area
- Marquette UniversityUndergraduate Researcher2012Greater Milwaukee
- Erie County Public Health LaboratoryIntern2012Buffalo-Niagara Falls Area
- Boston UniversitySummer Institute for Training in Biostatistics2011Greater Boston
- Haledyne Inc.Research Intern2011Syracuse, New York Area
Skills & more
R1SAS ProgramingBiostatistics2Epidemiology1Statistics1C++RubyUbuntuMicrosoft Office1Open OfficeViolaResearch1
+7 more
Molecular BiologyClinical TrialsCellChemistryBiologyPCRSASFrom Maxwell's professional profile.
Colleagues at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital
Frequently asked questions
- Who is Maxwell DeNies?
- Maxwell DeNies is an Analyst on the investment team at RA Capital Management, where he conducts due diligence on biotechnology companies and advises portfolio companies on program and pipeline strategy. He holds a BS in Biology from the State University of New York at Fredonia and a PhD in Cellular and Molecular Biology from the University of Michigan. He joined RA Capital in 2020.
- Where does Maxwell DeNies work?
- Maxwell DeNies is Analyst at RA Capital.
- What does Maxwell DeNies invest in?
- Maxwell DeNies invests in Biotech.
- What check size does Maxwell DeNies write?
- Maxwell DeNies typically writes checks of $100K – $5M.
- Where did Maxwell DeNies go to school?
- Maxwell DeNies studied at University of Michigan (Doctor of Philosophy (PhD), Cell/Cellular and Molecular Biology); State University of New York at Fredonia (BS Biology); Boston University (Summer Institute for Training in Biostatistics).
Same school
Also attended University of Michigan517
Erik TorenbergGeneral Partner at Andreessen Horowitz; founder of TurpentineKarim FarisInvestor at GV (Google Ventures)Glen AndersonPartner at Monta Vista CapitalAlexandra FarmerPrincipal at Intel Capital, North AmericaHannah KrootMarketing Lead at Intel CapitalScott ShawChief of Staff at Intel Capital
+ 511 more
Also attended State University of New York at Fredonia2
Shared employers
Also worked at University of Michigan116
Alexandra FarmerPrincipal at Intel Capital, North AmericaLogan HilleLife Sciences Analyst at CincyTechSara Risch, PhDAdvisor at CincyTechPeter GiordanoFormer Global Director GTM Strategy at Scale Venture PartnersPaul BrownManaging Director at eLab VenturesDoug NealManaging Director at eLab Ventures
+ 110 more
Also worked at University of Michigan Ross School of Business16
Alexandra FarmerPrincipal at Intel Capital, North AmericaDan StolarVenture Advisor at Alpha PartnersMeredith Breach BosPrincipal — Endurance at Energize VenturesSushmita MukherjeeInvestor at SUPPLY CHANGE CAPITALProf. Annie KohAdvisor at iGlobe PartnersBob BarnettIII, Managing Partner at Phoenix Sports Partners
+ 10 more
Also worked at UCSF84
Logan HilleLife Sciences Analyst at CincyTechPaul JennyBoard Chair at CincyTechDavid KaufmanInvestor at Third Rock VenturesFrancisco GimenezInvestment Team at 8VCHani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersCharles White, Ph.D.Principal at Illumina Ventures
+ 78 more
